Recombinant Human Cyclin Dependent Kinase Inhibitor 1B (CDKN1B), Unconjugated

Produktübersicht

• Artikelname: Recombinant Human Cyclin Dependent Kinase Inhibitor 1B (CDKN1B), Unconjugated
• Artikelnummer: BIM-RPU50276
• Hersteller Artikelnummer: RPU50276
• Alternativnummer: BIM-RPU50276-50UG, BIM-RPU50276-100UG, BIM-RPU50276-1MG
• Hersteller: Biomatik Corporation
• Kategorie: Proteine/Peptide
• Applikation: Control, SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: CDKN4, KIP1, P27KIP1, p27, Cyclin-dependent kinase inhibitor p27

Produktbeschreibung

Recombinant Human Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Cyclin Dependent K

Produkteigenschaften

• Molekulargewicht: 30kDa
• Tag: N-terminal His Tag
• NCBI: 1027
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Reinheit: >90% by SDS-PAGE
• Formulierung: Freeze-Dried Powder
• Target-Kategorie: Cyclin Dependent Kinase Inhibitor 1B (CDKN1B)